Home›Stock Screener›Advanced Enzyme Tech›Quarterly Results

Advanced Enzyme Tech Quarterly Results

Latest Quarter Net Profit
₹51 Cr
QSept 2026
Quarterly Results

Advanced Enzyme Tech quarterly results. In Sept 2026, Advanced Enzyme Tech (ADVENZYMES) reported revenue ₹223 Cr and net profit ₹51 Cr — revenue +14.4% YoY. Also explore Advanced Enzyme Tech share price performance to track price trends across different timeframes.

ADVENZYMES Quarterly Results — Revenue, Profit & EPS Highlights

Advanced Enzyme Tech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View ADVENZYMES 52-week performance for the annual high/low range and current price position.

  • Revenue of ₹223 Cr in Sept 2026 (+5.7% vs Mar 2026, +14.4% vs Sept 2025)
  • Net Profit of ₹51 Cr in Sept 2026 (+13.3% vs Mar 2026, +13.3% vs Sept 2025)
  • EBITDA of ₹81 Cr in Sept 2026 (+14.1% vs Mar 2026)
  • Operating Margin of 34.0% in Sept 2026 (+3.0pp vs Mar 2026)
  • Earnings Per Share of ₹4.33 in Sept 2026 (+12.8% vs Mar 2026)

Advanced Enzyme Tech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ADVENZYMES quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 223 211 203 195 176 5.7% 14.4%
Net Profit (₹ Cr) 51 45 39 45 27 - -
EBITDA (₹ Cr) 81 71 64 70 54 - -
EPS (₹) 4.33 3.84 3.31 3.87 2.37 - -
Operating Margin (%) 34.0% 31.0% 28.0% 33.0% 27.0% - -

ADVENZYMES Share Price Trend — 1-Year Movement Across Quarterly Results

Advanced Enzyme Tech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Advanced Enzyme Tech share price chart.

Profitability Ratios

Profit Margin 22.9%
EBITDA Margin 36.3%
Operating Margin 34.0%
ROE (Annual) 12.1%

Balance Sheet Highlights

Total Assets ₹1,839 Cr
Total Equity ₹1,683 Cr
Current Assets ₹ Cr
Current Liabilities ₹49 Cr

Cash Flow Analysis

Operating Cash Flow ₹157 Cr
Investing Cash Flow ₹-72 Cr
Financing Cash Flow ₹-70 Cr
Net Cash Flow ₹15 Cr

Current Market Data

Current Price ₹296.25
Exchange NSE
Last Updated Nov 19, 2026

ADVENZYMES vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Advanced Enzyme Tech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores